Search

everythinglearnresearchcommunity

for

Search:↓

Critically ill patients may experience temporary hair loss after a fever.

The document's conclusion cannot be provided because the content is not accessible.

Telogen Effluvium is a common hair loss condition, particularly in women, with no specific FDA-approved treatment, and recovery can take up to 18 months.

COVID-19 may cause a common type of hair loss called telogen effluvium.

Telogen effluvium is a type of hair loss in women caused by many factors, and iron and thyroid tests are recommended for diagnosis.

Imiquimod used intravaginally for cervical issues can cause temporary hair loss, especially if severe side effects occur.

COVID-19 can cause intense hair loss in women, usually resolving in 1 to 4 months.

A 6-year-old girl experienced temporary hair loss after mild COVID-19, which improved naturally in 8 months.

Hair loss from Telogen Effluvium usually gets better within 6 months after addressing the cause.

Chronic telogen effluvium is a common hair loss condition with specific characteristics and treatment options.

Different types of hair loss within Telogen Effluvium are caused by various disruptions in hair growth cycles.

Most patients with telogen effluvium had low iron and vitamin D levels; iron supplements were commonly prescribed.

The poem reflects on hair loss, health concerns, and introspection.

A woman's use of minoxidil for hair loss caused fluid buildup in her chest, which went away when she stopped using the product.

Telogen effluvium negatively affects quality of life, increasing stress, depression, and anxiety.

COVID-19 can cause hair loss starting as early as 18 days after infection.

Hair loss in women can be caused by different conditions like hormonal changes, infections, or stress.

Hair loss from weight-loss treatments is usually temporary and reversible.

Telogen effluvium causes temporary hair loss, but new hair still grows.

COVID-19 may cause hair loss due to the virus's effects and stress from the pandemic.

COVID-19 has increased hair loss, but many patients see regrowth within months.

The document's conclusion cannot be determined from the provided text.

The document concludes that treating the underlying causes of telogen effluvium usually results in hair regrowth.

Hypothyroidism is often linked to the hair loss condition telogen effluvium.

Hair loss may be an early sign of serious illnesses like Hodgkin disease.

Low iron levels are linked to hair loss in adult women.

People with telogen effluvium often have much lower vitamin D levels than healthy individuals.

A woman's hair loss after COVID-19 was likely due to a mix of pressure-induced alopecia and acute telogen effluvium.

The author suggests changing "telogen effluvium" to "telogen defluxion" for hair loss terminology.

COVID-19 can cause different types of hair loss, which may last up to 100 days, and treatments are still being explored.